Plasmids were transformed into BL21-(DE3) competent cells (New England Biolabs), and proteins were expressed and purified as previously described (Ennist et al., 2022 (link)). Where noted, an additional purification step of high performance liquid chromatography (HPLC) was executed on a Waters reverse-phase HPLC system using a C4 or C18 HPLC column (Grace Davison Discovery Sciences). HPLC-pure samples were lyophilized and resuspended in >6.5 M GdnHCl, refolded by dilution, and purified by size exclusion chromatography (SEC) with Superdex 75 prep grade gel filtration medium (GE Healthcare Life Sciences).
Heterologous Expression and Purification of RC and DH Maquettes
Plasmids were transformed into BL21-(DE3) competent cells (New England Biolabs), and proteins were expressed and purified as previously described (Ennist et al., 2022 (link)). Where noted, an additional purification step of high performance liquid chromatography (HPLC) was executed on a Waters reverse-phase HPLC system using a C4 or C18 HPLC column (Grace Davison Discovery Sciences). HPLC-pure samples were lyophilized and resuspended in >6.5 M GdnHCl, refolded by dilution, and purified by size exclusion chromatography (SEC) with Superdex 75 prep grade gel filtration medium (GE Healthcare Life Sciences).
Corresponding Organization : University of Pennsylvania
Other organizations : Yale University, Yale Cancer Center
Variable analysis
- Mutagenesis primers provided by Invitrogen
- PCR amplification with AccuPrime™ Pfx SuperMix (Invitrogen)
- Protein expression and purification of RC maquette and DH maquette constructs
- HPLC purification of proteins
- Refolding of HPLC-pure samples in >6.5 M GdnHCl
- Purification of refolded proteins by size exclusion chromatography (SEC)
- N-terminal His6 tag followed by a TEV protease cleavage sequence in both gene constructs
- Transformation of plasmids into BL21-(DE3) competent cells (New England Biolabs)
- Protein expression and purification as previously described (Ennist et al., 2022)
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!